CERS
CERS
NASDAQ · Health Care

Cerus Corp

$1.82
+0.10 (+5.81%)
As of Mar 23, 10:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
206.94M
Net Income
-21,494,827
Gross Margin
59.9%
Profit Margin
-10.4%
Rev Growth
+8.1%
D/E Ratio
1.50
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 34.5% 34.5%
Operating Margin -7.1% -6.4% 20.6% 22.0%
Profit Margin -10.4% -9.9% 19.8% 14.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 206.94M 191.49M 130.22M 111.42M
Gross Profit 123.94M 114.68M 44.87M 38.39M
Operating Income -14,630,817 -12,184,450 26.88M 24.51M
Net Income -21,494,827 -17,900,753 25.78M 16.47M
Gross Margin 59.9% 59.9% 34.5% 34.5%
Operating Margin -7.1% -6.4% 20.6% 22.0%
Profit Margin -10.4% -9.9% 19.8% 14.8%
Rev Growth +8.1% +8.1% +7.1% +0.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 138.27M 138.27M 205.04M 167.58M
Total Equity 92.24M 92.24M 201.48M 187.99M
D/E Ratio 1.50 1.50 1.02 0.89
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,681,013 -9,389,249 34.32M 27.68M
Free Cash Flow 26.52M 27.45M